Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)

Disease Sites:

Head/Neck

Staging:

Early Phase I

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Kobayashi, Kenji

Scope:

Local

Participating Institutions:

Vanderbilt University

Open Date:

10-14-2026

Trial Type:

Diagnostic

Protocol ID:

VICCHN26044

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available